---
figid: PMC6825561__nihms-1537042-f0001
figlink: pmc/articles/PMC6825561/figure/F1/
number: F1
caption: Proposed scenario of current strategies targeting different traits of dysfunctional
  mitochondria in Alzheimer disease (AD), including mitochondrial bioenergetics and
  mitochondrial homeostasis. In the right part, therapeutic candidates that target
  glucose metabolism and/or the electron transport chain (ETC) are reported in red.
  J147 targets α- F1 subunit of ATP synthase (ATP5A) modulating its activity. Insulin
  rescues insulin resistance occurring in AD and improves glucose utilization. Thiamet
  G is a potent and specific inhibitor of OGA, an enzyme that controls GlcNAc cycling.
  Reduced GlcNAc levels are associated with reduced glucose uptake and result in altered
  mitochondria function. Vitamin C, MitoQ and a lipoic acid are antioxidant therapeutic
  candidates, used as beneficial supplements for AD patients. DNP (2,4-dinitrophenol)
  is a pharmacological uncoupler targeting UCPs present in the mitochondrial inner
  membrane. In the left part of the figure, therapeutic candidates targeting mitochondrial
  homeostasis that involves mitophagy and mitochondrial biogenesis, are shown in red.
  Resveratrol activates mitochondrial biogenesis by induction of SIRT1 or inhibition
  of cAMP phosphodiesterases. Metformin (Met) reduces ETC complex I activity, ultimately
  resulting in reduced ATP synthesis. Rapamycin is a potent and selective mTOR inhibitor
  able to regulate mitophagy. Latrepiridine and nicotinamide are both regulators of
  the autophagy pathway.
pmcid: PMC6825561
papertitle: 'Targeting Mitochondria in Alzheimer disease: Rationale and Perspectives.'
reftext: Chiara Lanzillotta, et al. CNS Drugs. ;33(10):957-969.
pmc_ranked_result_index: '53300'
pathway_score: 0.9579457
filename: nihms-1537042-f0001.jpg
figtitle: Proposed scenario of current strategies targeting different traits of dysfunctional
  mitochondria in Alzheimer disease (AD), including mitochondrial bioenergetics and
  mitochondrial homeostasis
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6825561__nihms-1537042-f0001.html
  '@type': Dataset
  description: Proposed scenario of current strategies targeting different traits
    of dysfunctional mitochondria in Alzheimer disease (AD), including mitochondrial
    bioenergetics and mitochondrial homeostasis. In the right part, therapeutic candidates
    that target glucose metabolism and/or the electron transport chain (ETC) are reported
    in red. J147 targets α- F1 subunit of ATP synthase (ATP5A) modulating its activity.
    Insulin rescues insulin resistance occurring in AD and improves glucose utilization.
    Thiamet G is a potent and specific inhibitor of OGA, an enzyme that controls GlcNAc
    cycling. Reduced GlcNAc levels are associated with reduced glucose uptake and
    result in altered mitochondria function. Vitamin C, MitoQ and a lipoic acid are
    antioxidant therapeutic candidates, used as beneficial supplements for AD patients.
    DNP (2,4-dinitrophenol) is a pharmacological uncoupler targeting UCPs present
    in the mitochondrial inner membrane. In the left part of the figure, therapeutic
    candidates targeting mitochondrial homeostasis that involves mitophagy and mitochondrial
    biogenesis, are shown in red. Resveratrol activates mitochondrial biogenesis by
    induction of SIRT1 or inhibition of cAMP phosphodiesterases. Metformin (Met) reduces
    ETC complex I activity, ultimately resulting in reduced ATP synthesis. Rapamycin
    is a potent and selective mTOR inhibitor able to regulate mitophagy. Latrepiridine
    and nicotinamide are both regulators of the autophagy pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APP
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - IRS1
  - IRS4
  - IRS2
  - ULK2
  - ULK1
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - SIRT1
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - SLTM
  - TFAM
  - NRF1
  - Glucose
  - Glucose-6-P
  - Latrepiridine
  - GlcNAC
  - Pyruvate
  - Nicotinamide Resveratrol
  - Rapamycin
  - Vitamin C
  - NAD++
  - FAD
  - NADH
  - H
  - ATP
  - Resveratrol
  - MITOCHONDRIAL
  - Glucose-6-P
  - OXIDATIVE
genes:
- word: APP
  symbol: APP
  source: hgnc_symbol
  hgnc_symbol: APP
  entrez: '351'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: ULK1/2
  symbol: ULK2
  source: hgnc_symbol
  hgnc_symbol: ULK2
  entrez: '9706'
- word: ULK1/2
  symbol: ULK1
  source: hgnc_symbol
  hgnc_symbol: ULK1
  entrez: '8408'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: SIRT1
  symbol: SIRT1
  source: hgnc_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: TFAM
  symbol: TFAM
  source: hgnc_symbol
  hgnc_symbol: TFAM
  entrez: '7019'
- word: NRF1
  symbol: NRF1
  source: hgnc_symbol
  hgnc_symbol: NRF1
  entrez: '4899'
- word: +NRF1
  symbol: NRF1
  source: hgnc_symbol
  hgnc_symbol: NRF1
  entrez: '4899'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glucose-6-P
  source: MESH
  identifier: D005947
- word: Latrepiridine
  source: ''
  identifier: ''
- word: GlcNAC
  source: MESH
  identifier: C086501
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Nicotinamide Resveratrol
  source: MESH
  identifier: C059514
- word: Rapamycin
  source: MESH
  identifier: D020123
- word: Vitamin C
  source: MESH
  identifier: D001205
- word: NAD++
  source: MESH
  identifier: D009243
- word: FAD
  source: MESH
  identifier: D005182
- word: NADH
  source: MESH
  identifier: D009243
- word: H
  source: MESH
  identifier: D006859
- word: ATP
  source: MESH
  identifier: D000255
- word: Resveratrol
  source: MESH
  identifier: C059514
diseases:
- word: MITOCHONDRIAL
  source: MESH
  identifier: D028361
- word: Glucose-6-P
  source: MESH
  identifier: C537241
- word: OXIDATIVE
  source: MESH
  identifier: D004194
figid_alias: PMC6825561__F1
redirect_from: /figures/PMC6825561__F1
figtype: Figure
---
